rs886039608
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_021222.3(PRUNE1):c.521-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_021222.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRUNE1 | NM_021222.3 | c.521-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 7 | ENST00000271620.8 | NP_067045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460198Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726382
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies Pathogenic:1
- -
PRUNE1-related disorder Pathogenic:1
The PRUNE1 c.521-2A>G variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant has been reported in the homozygous state in three related and four additional unrelated individuals of Cree or Oji-Cree ancestry, with severe developmental delay, talipes equinovarus, contractures, hypotonia, and brain malformations apparent at birth or manifesting within the first 1-2 years of life (Costain et al. 2017. PubMed ID: 28211990; Hartley et al. 2018. PubMed ID: 30556349). RT-PCR studies showed the c.521-2A>G variant leads to aberrant splicing (Hartley et al. 2018. PubMed ID: 30556349). The c.521-2A>G variant has been suggested to a founder variant in the Cree population (Hartley et al. 2018. PubMed ID: 30556349). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Variants that disrupt the consensus splice acceptor site in PRUNE1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
The c.521-2A>G variant in the PRUNE gene has been reported previously in the homozygous state in an individual with a history of severe developmental delay, cortical blindness, infantile spasms, and central hypoventilation (Costain et al., 2017). This splice site variant destroys the canonical splice acceptor site in intron 4. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.521-2A>G variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.521-2A>G as a likely pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at